| Protective effect of let-7 miRNA family in regulating inflammation in diabetes-associated atherosclerosis E Brennan, B Wang, A McClelland, M Mohan, M Marai, O Beuscart, ... Diabetes 66 (8), 2266-2277, 2017 | 163 | 2017 |
| Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis EP Brennan, M Mohan, A McClelland, M Gaetano, C Tikellis, M Marai, ... Diabetes 67 (12), 2657-2667, 2018 | 66 | 2018 |
| Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease EP Brennan, M Mohan, A McClelland, C Tikellis, M Ziemann, A Kaspi, ... Journal of the American Society of Nephrology 29 (5), 1437-1448, 2018 | 52 | 2018 |
| Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease T Fu, M Mohan, EP Brennan, OL Woodman, C Godson, P Kantharidis, ... ACS pharmacology & translational science 3 (1), 43-55, 2020 | 44 | 2020 |
| RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis S Hagiwara, K Sourris, M Ziemann, W Tieqiao, M Mohan, AD McClelland, ... Diabetes 67 (5), 960-973, 2018 | 21 | 2018 |
| Specialized pro-resolving mediators in diabetes: novel therapeutic strategies EP Brennan, M Mohan, D Andrews, M Bose, P Kantharidis Clinical Science 133 (21), 2121-2141, 2019 | 16 | 2019 |
| Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation KC Sourris, Y Ding, SS Maxwell, A Al-Sharea, P Kantharidis, M Mohan, ... Kidney International 105 (1), 132-149, 2024 | 3 | 2024 |
| Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase (sGC) A Sharma, J Choi, L Sim, A Dey, M Mohan, P Kantharidis, L Dietz, ... Frontiers in Cardiovascular Medicine 10, 1220095, 2023 | 1 | 2023 |
| Transflection infrared spectroscopy as a rapid screening tool for urinary 8-isoprostane A Kincses, KC Sourris, M Mohan, P Kantharidis, K Jandeleit-Dahm, ... Microchemical Journal 181, 107641, 2022 | 1 | 2022 |
| The protective role of Lipoxins against diabetes-associated atherosclerosis M Mohan Monash University, 2020 | | 2020 |
| Therapeutic Actions Of Pro-Resolving Lipoxin A4 Mimetics Against Atherosclerosis M Mohan, AMD Watson, KC Sourris, EP Brennan, C Godson, ME Cooper, ... Atherosclerosis 287, e100, 2019 | | 2019 |
| SAT-297 PRO-RESOLVING ACTIONS OF LIPOXIN A4 MIMETICS AGAINST DIABETIC NEPHROPATHY M MOHAN, S Nazari, KC Sourris, EP Brennan, C Godson, ME Cooper, ... Kidney International Reports 4 (7), S132-S133, 2019 | | 2019 |
| Lipoxin A4 Protects Against Diabetic Nephropathy In Part by Attenuating The NLRP3 Inflammasome ME Cooper, M Mohan, S Nazari, KC Sourris, EP Brennan, C Godson, ... 2019 Keystone Symposia Conference X4: Unraveling the Secrets of Kidney …, 2019 | | 2019 |
| 112 Lipoxin A4 as a novel therapeutic approach to limit diabetes-induced cardiac remodelling CX Qin, EP Brennan, CUH Lam, M Mohan, M Deo, N Matthew, M Tare, ... XXIII World Congress of the International Society of Heart Research, 108, 2019 | | 2019 |
| The protective role of Lipoxins against Diabetes-associated atherosclerosis M Mohan, EP Brennan, AD McClelland, K Jandeleit-Dahm, ME Cooper, ... Strategy Day for Obesity and Diabetes Research, Melbourne, 2018 | | 2018 |
| Targeting Inflammation in Diabetic Kidney Disease Using Pro-Resolving Lipid Mediators EP Brennan, M Mohan, A McClelland, C Tikellis, M Ziemann, A Kaspi, ... Vascular Biology and Human Diseases: From Molecular Pathways to Novel …, 2018 | | 2018 |
| Targeting Inflammation in Diabetic Kidney Disease Using Pro-Resolving Lipid Mediators EP Brennan, M Mohan, A McClelland, C Tikellis, M Ziemann, A Kaspi, ... Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ …, 2018 | | 2018 |
| The therapeutic role of Lipoxin A4 and Benzo-lipoxin against Diabetes-associated atherosclerosis M Mohan, E Brennan, AD McClelland, K Jandeleit-Dahm, ME Cooper, ... The Alfred Health Week, 37, 2018 | | 2018 |
| Lipoxins Attenuate Diabetic Complications in the ApoE-/- Mouse EP Brennan, M Mohan, M De gaetano, C Tikellis, M Marai, M Ziemann, ... Journal of American Society of Nephrology | Kidney Week 28, 753, 2017 | | 2017 |
| Lipoxins Attenuate Kidney Disease Progression in Diabetic ApoE-/- Mice P Kantharidis, ME Cooper, M Mohan, AD McClelland, K Jandeleit-Dahm, ... Journal of American Society of Nephrology | Kidney Week 27, 142A, 2016 | | 2016 |
Phillip KantharidisVerified email at monash.edu
